Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Minoxidil can help regrow hair in alopecia areata patients.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

New alopecia treatments aim for better results and fewer side effects.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

People with HIV and low T cell counts have more hair and scalp problems.

Steroids are the best treatment for Alopecia Areata with few side effects.

Minoxidil may help hair growth by stopping immune system attacks on hair follicles.

Minoxidil cream can safely treat hair loss in kids with ectodermal dysplasia.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Ciclosporin might be a good alternative treatment for certain hearing loss that responds to steroids.

PRP injections safely increase hair density and thickness in androgenetic alopecia.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Higher IL-17A levels indicate more severe alopecia areata.

The document is a detailed medical reference on skin and genetic disorders.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Azathioprine may be an effective treatment for severe hair loss.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

The document concludes that "Photodamage" and "Photoimmunology" are valuable resources, while "Pediatric Dermatopathology" and "Hair and Scalp Disorders" have limitations.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.